Abstract Body

Background

Underdiagnosis remains a major barrier to Hepatitis C (HCV) elimination. The ATENEA study assesses whether the implementation of rapid testing combined with a self-administered risk assessment in Primary Care (PC) settings could enhance HCV detection.

Methods

This is a cluster-randomized, stepped-wedge trial (clinicaltrials.gov ID: NCT06528626) conducted across eight PC centers between July 2023 and February 2025. An initial 4-month observation phase (July–October 2022) was implemented in all centers, followed by 4-month intervention periods:

  1. Control (standard practice after training on HIV screening)
  2. Rapid hepatitis C testing (RT)
  3. Combined intervention (RT + self-administered risk questionnaire; RT+Q)

Intervention type was modeled as a categorical variable with four levels, using the observation phase as the reference. We calculated HCV screening coverage (HCV tests performed) and total and new HCV diagnoses per 100,000 patients attended. Poisson regression models, adjusted for period and clustering by center, were fitted to estimate incidence rate ratios (IRRs) with 95% confidence intervals. 

Results

A total of 40 center-period observations were analyzed. The study population included 237,670 individuals, with 14,975 HCV tests performed, yielding 208 positive results (26 newly diagnosed).

Compared with the observation phase (2,120 HCV tests were conducted with 23 positives),  HCV Screening rates increased by 124% in the RT+Q phase (IRR = 2.24; 95% CI: 2.00–2.50; p < 0.001) and by 96% in the RT phase (IRR = 1.96; 95% CI: 1.34–2.87; p = 0.001), while Control phase demonstrated a non-significant increase (IRR = 1.54; p = 0.131). The Prevalence of Anti-HCV significantly increased in the RT+Q phase (IRR = 2.83; 95% CI: 1.95–4.13; p < 0.001), with non-significant upward trend in RT phase (IRR = 1.75; p = 0.105), and Control phase revealed no differences (IRR = 0.84; p = 0.799). Figure 1. 

Conclusions

The implementation of rapid hepatitis C testing combined with self-administered risk questionnaires in Primary Care significantly enhances screening activity.

Table or Figure